Global Netupitant-Palonosetron FDC Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1084

The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV).
Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
North America was the dominant regional market for netupitant‐palonosetron FDC drugs, in terms of revenue, due to growth in incidence of CINV among patients.
In 2018, the global Netupitant-Palonosetron FDC market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Netupitant-Palonosetron FDC status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Netupitant-Palonosetron FDC development in United States, Europe and China.

The key players covered in this study
Eisai Pharmaceutical
Helsinn
Heron Therapeutics
Tesaro
Acacia Pharma
...

Market segment by Type, the product can be split into
Flakes
Capsules
Other

Market segment by Application, split into
Hospital Pharmacy
Drug Stores
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Netupitant-Palonosetron FDC status, future forecast, growth opportunity, key market and key players.
To present the Netupitant-Palonosetron FDC development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Netupitant-Palonosetron FDC are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Netupitant-Palonosetron FDC Market Size Growth Rate by Type (2014-2025)
1.4.2 Flakes
1.4.3 Capsules
1.4.4 Other
1.5 Market by Application
1.5.1 Global Netupitant-Palonosetron FDC Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Drug Stores
1.5.4 Retail Pharmacy
1.5.5 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Netupitant-Palonosetron FDC Market Size
2.2 Netupitant-Palonosetron FDC Growth Trends by Regions
2.2.1 Netupitant-Palonosetron FDC Market Size by Regions (2014-2025)
2.2.2 Netupitant-Palonosetron FDC Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Netupitant-Palonosetron FDC Market Size by Manufacturers
3.1.1 Global Netupitant-Palonosetron FDC Revenue by Manufacturers (2014-2019)
3.1.2 Global Netupitant-Palonosetron FDC Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Netupitant-Palonosetron FDC Market Concentration Ratio (CR5 and HHI)
3.2 Netupitant-Palonosetron FDC Key Players Head office and Area Served
3.3 Key Players Netupitant-Palonosetron FDC Product/Solution/Service
3.4 Date of Enter into Netupitant-Palonosetron FDC Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Netupitant-Palonosetron FDC Market Size by Type (2014-2019)
4.2 Global Netupitant-Palonosetron FDC Market Size by Application (2014-2019)

5 United States
5.1 United States Netupitant-Palonosetron FDC Market Size (2014-2019)
5.2 Netupitant-Palonosetron FDC Key Players in United States
5.3 United States Netupitant-Palonosetron FDC Market Size by Type
5.4 United States Netupitant-Palonosetron FDC Market Size by Application

6 Europe
6.1 Europe Netupitant-Palonosetron FDC Market Size (2014-2019)
6.2 Netupitant-Palonosetron FDC Key Players in Europe
6.3 Europe Netupitant-Palonosetron FDC Market Size by Type
6.4 Europe Netupitant-Palonosetron FDC Market Size by Application

7 China
7.1 China Netupitant-Palonosetron FDC Market Size (2014-2019)
7.2 Netupitant-Palonosetron FDC Key Players in China
7.3 China Netupitant-Palonosetron FDC Market Size by Type
7.4 China Netupitant-Palonosetron FDC Market Size by Application

8 Japan
8.1 Japan Netupitant-Palonosetron FDC Market Size (2014-2019)
8.2 Netupitant-Palonosetron FDC Key Players in Japan
8.3 Japan Netupitant-Palonosetron FDC Market Size by Type
8.4 Japan Netupitant-Palonosetron FDC Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Netupitant-Palonosetron FDC Market Size (2014-2019)
9.2 Netupitant-Palonosetron FDC Key Players in Southeast Asia
9.3 Southeast Asia Netupitant-Palonosetron FDC Market Size by Type
9.4 Southeast Asia Netupitant-Palonosetron FDC Market Size by Application

10 India
10.1 India Netupitant-Palonosetron FDC Market Size (2014-2019)
10.2 Netupitant-Palonosetron FDC Key Players in India
10.3 India Netupitant-Palonosetron FDC Market Size by Type
10.4 India Netupitant-Palonosetron FDC Market Size by Application

11 Central & South America
11.1 Central & South America Netupitant-Palonosetron FDC Market Size (2014-2019)
11.2 Netupitant-Palonosetron FDC Key Players in Central & South America
11.3 Central & South America Netupitant-Palonosetron FDC Market Size by Type
11.4 Central & South America Netupitant-Palonosetron FDC Market Size by Application

12 International Players Profiles
12.1 Eisai Pharmaceutical
12.1.1 Eisai Pharmaceutical Company Details
12.1.2 Company Description and Business Overview
12.1.3 Netupitant-Palonosetron FDC Introduction
12.1.4 Eisai Pharmaceutical Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
12.1.5 Eisai Pharmaceutical Recent Development
12.2 Helsinn
12.2.1 Helsinn Company Details
12.2.2 Company Description and Business Overview
12.2.3 Netupitant-Palonosetron FDC Introduction
12.2.4 Helsinn Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
12.2.5 Helsinn Recent Development
12.3 Heron Therapeutics
12.3.1 Heron Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Netupitant-Palonosetron FDC Introduction
12.3.4 Heron Therapeutics Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
12.3.5 Heron Therapeutics Recent Development
12.4 Tesaro
12.4.1 Tesaro Company Details
12.4.2 Company Description and Business Overview
12.4.3 Netupitant-Palonosetron FDC Introduction
12.4.4 Tesaro Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
12.4.5 Tesaro Recent Development
12.5 Acacia Pharma
12.5.1 Acacia Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Netupitant-Palonosetron FDC Introduction
12.5.4 Acacia Pharma Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
12.5.5 Acacia Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details